SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001693011-17-000003
Filing Date
2017-01-12
Accepted
2017-01-12 10:23:55
Documents
1
Effectiveness Date
2017-01-12
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 5604
  Complete submission text file 0001693011-17-000003.txt   6717
Mailing Address 240 BLUFF VIEW DRIVE GUILFORD CT 06347
Business Address 240 BLUFF VIEW DRIVE GUILFORD CT 06347 2034423597
Inozyme Pharma, Inc. (Filer) CIK: 0001693011 (see all company filings)

IRS No.: 475129768 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-277738 | Film No.: 17524134